Discover 2,007 paid clinical trials in Fort Lauderdale, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,007
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
for
Refractory Metastatic Colorectal Cancer
Location: Miami FL, Tampa FL, New Orleans LA, Chapel Hill NC,
Sponsor: Delcath Systems Inc.
Sex: All
Age: 18+
Code: NCT06607458
Phase 2, Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
for
Metastatic Pancreatic Ductal Adenocarcinoma,
Location: Miami FL
Sponsor: Benjamin Spieler
Sex: All
Age: 18+
Code: NCT06843551
Phase 2, Recruiting
Preoperative Comprehensive Geriatric Assessment (CGA) and Postoperative Delirium
for
CGA
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 60+
Code: NCT07059585
Recruiting
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
for
Bone Marrow Transplant Complications, Graft-versus-Host Disease
Location: Miami FL, Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06910969
Recruiting
Diagnosing Epilepsy To EffeCT Change
for
Epilepsy, Epilepsy (Treatment Refractory)
Location: Miami FL, Tampa FL, Jacksonville FL, Charlotte NC,
Sponsor: Epiminder America, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07110337
Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Miami FL, Tampa FL, Jacksonville FL, Greenville NC,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase 2, Phase 3, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Miami FL, West Palm Beach FL, Fort Myers FL, Orlando FL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer